128 related articles for article (PubMed ID: 2139220)
1. [Limitations of prenatal treatment of congenital toxoplasmosis with a sulfadiazine-pyrimethamine combination].
Boulot P; Pratlong F; Sarda P; Deschamps F; Hedon B; Laffargue F; Viala JL
Presse Med; 1990 Mar; 19(12):570. PubMed ID: 2139220
[No Abstract] [Full Text] [Related]
2. [Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)].
Couvreur J; Nottin N; Desmonts G
Ann Pediatr (Paris); 1980 Dec; 27(10):647-52. PubMed ID: 7212550
[No Abstract] [Full Text] [Related]
3. [Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides].
Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
Arch Fr Pediatr; 1991; 48(6):397-403. PubMed ID: 1929726
[TBL] [Abstract][Full Text] [Related]
4. Serologic rebounds after one-year-long treatment for congenital toxoplasmosis.
Djurkovic-Djakovic O; Romand S; Nobrè R; Couvreur J; Thulliez P
Pediatr Infect Dis J; 2000 Jan; 19(1):81-3. PubMed ID: 10643858
[No Abstract] [Full Text] [Related]
5. [Recommendations for the treatment of prenatal toxoplasma infection in the child. German Society of Pediatric Infectiology e.V. (DGPI), "Parasitology" Study Group].
Döhring-Schwerdtfeger E; Leichsenring M; Liefke U; Padelt H; Sitzmann FC; Stehr K; Zimmermann PH
Klin Padiatr; 1995; 207(1):38-41. PubMed ID: 7885018
[No Abstract] [Full Text] [Related]
6. [Sulfadiazine, pyrimethamine, spiramycin and folic acid in congenital toxoplasmosis].
Sedan J
Mars Med; 1967; 104(4):343-5. PubMed ID: 5621539
[No Abstract] [Full Text] [Related]
7. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases].
Kieffer F; Thulliez P; Brézin A; Nobre R; Romand S; Yi-Gallimard E; Voyer M; Magny JF
Arch Pediatr; 2002 Jan; 9(1):7-13. PubMed ID: 11865553
[TBL] [Abstract][Full Text] [Related]
9. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine.
Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
Fetal Diagn Ther; 1993; 8(1):45-50. PubMed ID: 8452648
[TBL] [Abstract][Full Text] [Related]
10. [Postnatal therapy for congenital toxoplasmosis: a comparison of 2 different treatment approaches].
Pohl-Schickinger A; Feiterna-Sperling C; Weizsäcker K; Bührer C
Z Geburtshilfe Neonatol; 2012 Apr; 216(2):73-6. PubMed ID: 22517047
[TBL] [Abstract][Full Text] [Related]
11. [Toxoplasmosis].
Maeda T
Nihon Rinsho; 2003 Feb; 61 Suppl 2():603-7. PubMed ID: 12722288
[No Abstract] [Full Text] [Related]
12. [In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination].
Couvreur J
Presse Med; 1991 Jun; 20(24):1136. PubMed ID: 1830148
[No Abstract] [Full Text] [Related]
13. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
[TBL] [Abstract][Full Text] [Related]
14. [Strategies for the diagnosis and treatment of prenatal toxoplasmosis - a survey].
Christoph J; Kattner E; Seitz HM; Reiter-Owona I
Z Geburtshilfe Neonatol; 2004 Feb; 208(1):10-6. PubMed ID: 15039886
[TBL] [Abstract][Full Text] [Related]
15. Unresolved questions about the most successful known parasite.
Ajzenberg D
Expert Rev Anti Infect Ther; 2011 Feb; 9(2):169-71. PubMed ID: 21342063
[TBL] [Abstract][Full Text] [Related]
16. Congenital toxoplasmosis in a neonate with significant neurologic manifestations.
Chuang YC; Chen JY; Ji DD; Su PH
J Formos Med Assoc; 2012 Apr; 111(4):232-3. PubMed ID: 22526213
[No Abstract] [Full Text] [Related]
17. Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection--own observations.
Lipka B; Milewska-Bobula B; Filipek M
Wiad Parazytol; 2011; 57(2):87-92. PubMed ID: 21682092
[TBL] [Abstract][Full Text] [Related]
18. Treatment of congenital toxoplasmosis.
Wilson CB
Pediatr Infect Dis J; 1990 Sep; 9(9):682-3. PubMed ID: 2235199
[No Abstract] [Full Text] [Related]
19. [Toxoplasmosis retinochorioiditis, a therapy comparison between spiramycin and pyrimethamine/sulfadiazine].
Hacker M; Richter R; Gümbel H; Richter T; Ohrloff C
Klin Monbl Augenheilkd; 1998 Feb; 212(2):84-7. PubMed ID: 9577806
[TBL] [Abstract][Full Text] [Related]
20. Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.
Schmidt DR; Hogh B; Andersen O; Hansen SH; Dalhoff K; Petersen E
Eur J Pediatr; 2006 Jan; 165(1):19-25. PubMed ID: 16133245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
